Menu Search
Equities

BioRegenx Inc

BRGX:PKL

BioRegenx Inc

Actions
Consumer DiscretionaryMedia
  • Price (USD)0.0161
  • Today's Change-0.002 / -10.00%
  • Shares traded1.45k
  • 1 Year change-51.33%
  • Beta-2.7763
Data delayed at least 15 minutes, as of Sep 20 2024 16:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year BioRegenx Inc's revenues fell -47.25% from 42.16k to 22.24k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 78.31k to a larger loss of 571.17k.
Gross margin74.90%
Net profit margin-114.67%
Operating margin-102.97%
Return on assets-7.07%
Return on equity-8.64%
Return on investment-8.46%
More ▼

Cash flow in USDView more

In 2023, cash reserves at BioRegenx Inc fell by 680.00. Cash Flow from Financing totalled 12.67k or 56.97% of revenues. In addition the company used 13.35k for operations while cash from investing was breakeven.
Cash flow per share-0.0013
Price/Cash flow per share--
Book value per share0.0178
Tangible book value per share-0.0016
More ▼

Balance sheet in USDView more

BioRegenx Inc has a Debt to Total Capital ratio of 9.77%.
Current ratio0.2766
Quick ratio0.1547
Total debt/total equity0.1083
Total debt/total capital0.0977
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.